APP and Alzheimer disease: We previously demonstrated that DNMT1 mRNA levels are not regulated in buffy coat samples from patients with AD [57], whereas DNMT3a expression is downregulated in buffy coats from dementia patients and in the brain of saline-treated APP/BIN1/COPS5 AD mice [57].